List of insiders holdings for Ovid Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | During Matthew Director 10% Owner |
2022-02-14 17:29:47 | 3,103,932 0 |
3,103,932 | Form 13G |
| 2 | LEVIN JEREMY M CEO |
2025-02-24 19:55:09 | 1,650,000 0 |
1,650,000 | Form 4 |
| 3 | Rakhit Amit President and CMO |
2021-07-16 18:21:39 | 817,806 0 |
817,806 | Form 4 |
| 4 | Perone Thomas Michael General Counsel, Secretary |
2024-02-26 18:00:45 | 196,875 0 |
196,875 | Form 4 |
| 5 | Tardio Jason Chief Operating Officer |
2024-02-26 18:05:11 | 196,875 0 |
196,875 | Form 4 |
| 6 | Werber Yaron CBO, CFO, Sec. and Treas. |
2018-01-23 16:47:05 | 131,000 0 |
131,000 | Form 4 |
| 7 | Daly Timothy EVP,Finance & Corp. Controller |
2020-12-21 16:34:43 | 125,000 0 |
125,000 | Form 4 |
| 8 | Haasner Dirk SVP, Global Regulatory Affairs |
2020-12-21 16:38:33 | 100,000 0 |
100,000 | Form 4 |
| 9 | PAPADOPOULOS STELIOS Director |
2025-03-04 16:44:34 | 90,000 0 |
90,000 | Form 4 |
| 10 | Bernstein Karen Director |
2024-12-16 16:15:15 | 90,000 0 |
90,000 | Form 4 |
| 11 | Duncan Barbara Gayle Director |
2024-12-16 16:15:16 | 90,000 0 |
90,000 | Form 4 |
| 12 | Friedman Bart Director |
2024-12-16 16:15:19 | 90,000 0 |
90,000 | Form 4 |
| 13 | Fitzgerald Kevin Joseph Director |
2024-12-16 16:15:20 | 90,000 0 |
90,000 | Form 4 |
| 14 | ALEXANDER MARGARET A. President and COO |
2025-02-28 16:15:10 | 73,406 0 |
73,406 | Form 4 |
| 15 | Rona Jeffrey A CBFO |
2025-02-28 16:15:08 | 67,973 0 |
67,973 | Form 4 |
| 16 | Ward Ana SVP and General Counsel |
2019-02-26 21:44:29 | 40,000 0 |
40,000 | Form 4 |
| 17 | Poole Robert Michael Director |
2024-02-26 18:01:37 | 30,000 0 |
30,000 | Form 4 |
| 18 | WILLIAMS DOUGLAS E Director |
2021-05-18 21:04:25 | 1,750 0 |
1,750 | Form 4 |
| 19 | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. 10% Owner |
2023-02-03 11:50:15 | 0 0 |
0 | Form 13G |
| 20 | TAKEDA PHARMACEUTICAL CO LTD MILLENNIUM PHARMACEUTICALS INC 10% Owner |
2023-02-03 11:50:15 | 0 0 |
0 | Form 13G |